PolyPeptide Group (Switzerland) Price on May 13, 2024
| PPGN Stock | CHF 28.95 0.45 1.58% |
If you're considering investing in PolyPeptide Stock, it is important to understand the factors that can impact its price. As of today, the current price of PolyPeptide Group stands at 28.95, as last reported on the 2nd of December, with the highest price reaching 29.10 and the lowest price hitting 28.15 during the day. PolyPeptide Group maintains Sharpe Ratio (i.e., Efficiency) of -0.0673, which implies the firm had a -0.0673% return per unit of risk over the last 3 months. PolyPeptide Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PolyPeptide Group's Risk Adjusted Performance of (0.06), variance of 6.46, and Coefficient Of Variation of (1,225) to confirm the risk estimate we provide.
PolyPeptide Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
PolyPeptide |
Sharpe Ratio = -0.0673
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PPGN |
Estimated Market Risk
| 2.55 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PolyPeptide Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PolyPeptide Group by adding PolyPeptide Group to a well-diversified portfolio.
PolyPeptide Group Valuation on May 13, 2024
It is possible to determine the worth of PolyPeptide Group on a given historical date. On May 13, 2024 PolyPeptide was worth 32.45 at the beginning of the trading date compared to the closed value of 33.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PolyPeptide Group stock. Still, in general, we apply an absolute valuation method to find PolyPeptide Group's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PolyPeptide Group where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PolyPeptide Group's related companies.
| Open | High | Low | Close | Volume | |
| 31.30 | 32.30 | 31.00 | 32.05 | 50,269 | |
05/13/2024 | 32.45 | 33.30 | 31.75 | 33.10 | 48,303 |
| 32.75 | 33.60 | 31.85 | 33.10 | 42,704 |
| Backtest PolyPeptide Group | | | PolyPeptide Group History | | | PolyPeptide Group Valuation | Previous | Next |
PolyPeptide Group Trading Date Momentum on May 13, 2024
| On May 14 2024 PolyPeptide Group AG was traded for 33.10 at the closing time. The highest price during the trading period was 33.60 and the lowest recorded bid was listed for 31.85 . The volume for the day was 42.7 K. This history from May 14, 2024 did not cause price change. The trading delta at closing time to the current price is 0.30% . |
PolyPeptide Group Fundamentals Correlations and Trends
By evaluating PolyPeptide Group's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PolyPeptide Group's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PolyPeptide financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PolyPeptide Group Stock history
PolyPeptide Group investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PolyPeptide is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PolyPeptide Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PolyPeptide Group stock prices may prove useful in developing a viable investing in PolyPeptide Group
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. The company was founded in 1952 and is headquartered in Zug, Switzerland. POLYPEPTIDE is traded on Switzerland Exchange in Switzerland.
PolyPeptide Group Stock Technical Analysis
PolyPeptide Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PolyPeptide Group Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
PolyPeptide Group AG cannot be verified against its exchange. Please verify the symbol is currently traded on SIX Swiss Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PolyPeptide Group December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how PolyPeptide Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PolyPeptide Group shares will generate the highest return on investment. By undertsting and applying PolyPeptide Group stock market strength indicators, traders can identify PolyPeptide Group AG entry and exit signals to maximize returns
PolyPeptide Group Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PolyPeptide Group's price direction in advance. Along with the technical and fundamental analysis of PolyPeptide Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PolyPeptide to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (1.22) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for PolyPeptide Stock Analysis
When running PolyPeptide Group's price analysis, check to measure PolyPeptide Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPeptide Group is operating at the current time. Most of PolyPeptide Group's value examination focuses on studying past and present price action to predict the probability of PolyPeptide Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPeptide Group's price. Additionally, you may evaluate how the addition of PolyPeptide Group to your portfolios can decrease your overall portfolio volatility.